CervoMed Inc. Acquisition Costs, Period Cost
CervoMed Inc. (CRVO) reported Acquisition Costs, Period Cost of $185.00 thousand for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AcquisitionCosts · last filed 2014-05-20
- CervoMed Inc. acquisition costs, period cost for the quarter ending 2014-03-31 was $185.00K.
| Period end | Acquisition Costs, Period Cost 3 month |
|---|---|
| 2014-03-31 | $185.00K 10-Q · filed 2014-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |